Essentials of Model-informed Drug Development in Oncology Blog Essentials of Model-informed Drug Development in Oncology Model-informed drug development in oncology is critical to developing safer and more effective cancer drugs.…CertaraOctober 6, 2025
Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science Announcement Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science Meet DIDB Concomitant Meds Navigator—an evidence-based tool to identify contraindicated or monitored co-medications and manage…CertaraSeptember 22, 2025
Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool Announcement Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool RADNOR, Pa. – September 17, 2025 – Certara, Inc. (Nasdaq: CERT), a global leader in…CertaraSeptember 17, 2025
Modeling Approaches for Determination of Pharmacokinetics/Pharmacodynamics Press Coverage Modeling Approaches for Determination of Pharmacokinetics/Pharmacodynamics Explore insights from Certara experts on how PK/PD modeling streamlines biologic drug development.CertaraAugust 5, 2025
Breaking New Ground: EMA Qualification of the Simcyp® Simulator Ushers in a New Era for PBPK Modeling Blog Breaking New Ground: EMA Qualification of the Simcyp® Simulator Ushers in a New Era for PBPK Modeling The Simcyp Simulator receives EMA qualification—the first and only PBPK platform formally qualified for any…CertaraAugust 5, 2025
Mechanistic Models at the Regulatory Frontier: Insights from EMA’s Qualification of the Simcyp® Simulator Webinar Mechanistic Models at the Regulatory Frontier: Insights from EMA’s Qualification of the Simcyp® Simulator CertaraAugust 4, 2025
Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling Press Release Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling Certara announces that EMA has formally qualified the Simcyp® Simulator for use in regulatory submissions…CertaraAugust 4, 2025
Certara’s Simcyp Educational Webinar Series Part 4: Changes in Drug Absorption after Meals and the Reality of Prediction Using Modeling Approaches [in Japanese] Webinar Certara’s Simcyp Educational Webinar Series Part 4: Changes in Drug Absorption after Meals and the Reality of Prediction Using Modeling Approaches [in Japanese] CertaraJuly 30, 2025
MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines On-Demand Webinar MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines Learn how clinical pharmacologists and modeling experts collaborate to improve preclinical-to-clinical translation.CertaraJuly 29, 2025